Skip to content
2000
Volume 10, Issue 6
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

Corticosteroid-induced hyperglycemia is a common medical problem which can cause frequent hospitalizations and therefore relates to an increase in morbidity. Metformin, sulfonylureas, thiazolidinediones and insulin are well known available therapies for the treatment of steroid induced hyperglycemia. Incretin based therapies are a newly developing strategies with a considerable importance in the treatment regimen as well. This review aims at discussing the pathophysiology of steroid induced hyperglycemia in addition to the available therapies used for treatment, focusing on incretin therapies.

Loading

Article metrics loading...

/content/journals/cdr/10.2174/1573399810666141015102900
2014-11-01
2025-05-25
Loading full text...

Full text loading...

/content/journals/cdr/10.2174/1573399810666141015102900
Loading

  • Article Type:
    Research Article
Keyword(s): corticosteroids; diabetes mellitus; Hyperglycemia; incretins
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test